Vuorela A, Mäntylä R, Männistö P T
Research Centre, Orion Pharmaceutica, Espoo, Finland.
Arzneimittelforschung. 1988 Apr;38(4A):628-30.
The tissue distribution of tritium-labelled vadocaine hydrochloride (2',4'-dimethyl-6'-methoxy-3-(2-methylpiperidyl)propionanilide+ ++ hydrochloride, OR K-242-HCl; INN: vadocaine) was studied in female mice by whole-body autoradiography at different times (15 min - 24 h) after intravenous injection. Radioactivity disappeared rapidly from blood and was fairly selectively localized in the liver, the gall bladder and the intestinal contents. Vadocaine is evidently metabolized in the liver and a remarkable part of the drug and its metabolites are excreted into the bile. Accumulation of radioactivity in the kidneys shows that also renal elimination is important. A considerable accumulation into the lungs supports the peripheral anaesthetizing mechanism in the antitussive action of vadocaine. No detectable penetration into the brain was seen. At 24 h, only traces of the radioactivity could be detected in the liver and lungs.
通过全身放射自显影技术,研究了静脉注射不同时间(15分钟至24小时)后,氚标记的盐酸瓦多卡因(2',4'-二甲基-6'-甲氧基-3-(2-甲基哌啶基)丙酰苯胺盐酸盐,或K-242-HCl;国际非专利药品名称:瓦多卡因)在雌性小鼠体内的组织分布。放射性物质迅速从血液中消失,并相当有选择性地定位在肝脏、胆囊和肠内容物中。瓦多卡因显然在肝脏中代谢,药物及其代谢产物的相当一部分被排泄到胆汁中。肾脏中放射性物质的积累表明肾脏排泄也很重要。肺部有相当程度的积累,这支持了瓦多卡因镇咳作用中的外周麻醉机制。未观察到可检测到的进入大脑的渗透。24小时时,在肝脏和肺部仅能检测到微量的放射性物质。